Biomarkers identifying hepatic inflammation in non-alcoholic fatty liver disease (NAFLD)

被引:0
|
作者
Werge, Mikkel [1 ]
Hoegl, Annabelle [2 ]
Therkelsen, Marie Louise [2 ]
Gronborg, Mads [2 ]
Mazzoni, Gianluca [2 ]
Harder, Lea Morch [2 ]
Hvid, Henning [2 ]
Rashu, Elias [1 ]
Thing, Mira [1 ]
Hetland, Liv [1 ]
Junker, Anders [1 ]
Serizawa, Reza [3 ]
Vyberg, Mogens [3 ,4 ]
Galsgaard, Elisabeth [2 ]
Gluud, Lise Lotte [5 ]
机构
[1] Copenhagen Univ Hosp Hvidovre, Gastro Unit, Hvidovre, Denmark
[2] Novo Nordisk AS, Res & Early Dev, Malov, Denmark
[3] Copenhagen Univ Hosp Hvidovre, Pathol, Hvidovre, Denmark
[4] Aalborg Univ, Ctr RNA Med, Copenhagen SV, Denmark
[5] Univ Copenhagen, Med Clin, Copenhagen N, Denmark
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
WED-411
引用
收藏
页码:S742 / S743
页数:2
相关论文
共 50 条
  • [21] Non-alcoholic Fatty Liver Disease Diagnosis and Therapy of NAFLD
    不详
    GASTROENTEROLOGE, 2021, 16 (05): : 386 - 386
  • [22] A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD)
    Puri, P.
    Baillie, R. A.
    Wiest, M.
    Mirshahi, F.
    Sanyal, A. J.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S260 - S261
  • [23] Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kosmalski, Marcin
    Drzewoski, Jozef
    Szymczak-Pajor, Izabela
    Zieleniak, Andrzej
    Mikolajczyk-Solinska, Melania
    Kasznicki, Jacek
    Sliwinska, Agnieszka
    BIOMEDICINES, 2022, 10 (09)
  • [24] Antiepileptic drugs and non-alcoholic fatty liver disease (NAFLD)
    Waldmann, M
    Sturm, W
    Naser, A
    Unterberger, I
    Trinka, E
    Bauer, G
    Lechleitner, M
    Luef, G
    EPILEPSIA, 2004, 45 : 161 - 162
  • [25] Diagnosis and management of non-alcoholic fatty liver disease (NAFLD)
    Byrne, C. D.
    POSTGRADUATE MEDICAL JOURNAL, 2018, 94 : A2 - A2
  • [26] Characterization of portal inflammation and hepatic fibrosis in non-alcoholic fatty liver disease
    Masters, Annie
    Estep, James M.
    Alaparthi, Lakshmi
    Bratthauer, Gary
    Birerdinc, Aybike
    Monge, Fanny
    Sharp, Cassandra
    Tan, Daisong
    Abdelaal, Hala
    Goodman, Zachary
    Younossi, Zobair
    JOURNAL OF HEPATOLOGY, 2023, 78 : S782 - S783
  • [27] Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
    Rong, Li
    Zou, Junyan
    Ran, Wei
    Qi, Xiaohong
    Chen, Yaokai
    Cui, Hongjuan
    Guo, Jinjun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [28] Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
    Tomasiewicz, Krzysztof
    Flisiak, Robert
    Halota, Waldemar
    Jaroszewicz, Jerzy
    Lebensztejn, Dariusz
    Lisik, Wojciech
    Malkowski, Piotr
    Pawlowska, Malgorzata
    Piekarska, Anna
    Simon, Krzysztof
    Tronina, Olga
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 153 - 157
  • [29] Non-Alcoholic Fatty Liver Disease (NAFLD) Management in the Community
    Park, Yongsoo
    Ko, Kyung Soo
    Rhee, Byoung Doo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [30] Prevalence of non-alcoholic fatty liver disease (NAFLD) in Singapore
    Tan, H. H.
    Chang, J. P. E.
    Chin, C.
    Tan, C. K.
    Lui, H. F.
    Chow, W. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A444 - A445